03:25 AM EDT, 04/01/2025 (MT Newswires) -- Michael F. Huang, Senior Vice President of Clinical Development, on March 27, 2025, sold 14,583 shares in Soleno Therapeutics ( SLNO ) for $1,013,627. Following the Form 4 filing with the SEC, Huang has control over a total of 36,817 common shares of the company, with 36,817 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1484565/000141588925009294/xslF345X05/form4-03312025_110347.xml